Bcg Vaccine Ajv

BCG Vaccine AJV is a live attenuated vaccine derived from Mycobacterium bovis, Danish Strain 1331. It is primarily used for the prevention of tuberculosis (TB) in infants and children. This intradermal vaccine is manufactured by Aj Vaccines A/S in the EU.

BCG Vaccine AJV is commonly administered to provide immunity against tuberculosis (TB). It is particularly recommended for infants and children in regions where TB is prevalent. The vaccine works by introducing a weakened form of the bacteria to stimulate the immune system, helping the body to recognize and fight off future TB infections. What is BCG Vaccine AJV used for? It is primarily used for the prevention of TB, especially in high-risk populations.

After receiving the BCG Vaccine AJV, some individuals may experience mild side effects at the injection site, such as redness, swelling, or a small bump. These effects are generally temporary and resolve on their own. In rare cases, more severe reactions may occur, and medical attention should be sought if symptoms persist or worsen.

BCG Vaccine AJV should be administered intradermally by a healthcare professional. It is important to inform the healthcare provider about any allergies or medical conditions before receiving the vaccine. Individuals with weakened immune systems or certain medical conditions may not be suitable candidates for this vaccine. Always follow the advice of a healthcare provider regarding vaccination.

There are limited known interactions with BCG Vaccine AJV. However, it is advisable to avoid other vaccines or medications around the time of BCG vaccination unless directed by a healthcare provider. Alcohol and certain medications may affect the immune system's response to the vaccine, so it is important to discuss any current treatments with a healthcare professional.